ICSs must iron out pharmacist prescribing ‘inconsistencies’, says Andrew Lane

NPA chair on the potential of community pharmacy amid ICB takeover

Integrated care systems (ICSs) must work to ensure that all pharmacists are offered appropriate prescribing opportunities, Andrew Lane has said.

Speaking at a Health and Social Care Committee event looking into the autonomy and accountability of ICSs today, the National Pharmacy Association chair praised ICCs for breaking down ‘silos’, but questioned the ‘inconsistencies’ between systems.

Related Article: OBE award the ‘pinnacle of my career’ says community pharmacist

For example, Mr Lane said that in Gloucestershire, where he chairs the local pharmaceutical committee (LPC), he has had discussions with GPs about how to help them get UTIs ‘off their desk’, but said there is no patient group direction (PGD) in the area to allow pharmacists to prescribe antibiotics for UTIs, unlike in other ICSs.

He continued: ‘More important things can be done by GPs; GPs want to get UTIs off their desk, so surely the system should be able to have PGDs for UTIs enabled? Our surrounding systems already have that in place.

‘So I think that’s just an example. You do have inconsistencies - and how you provide the accountability to ensure that that is covered across all systems is still a bit unclear.’

Mr Lane also suggested that ICSs should start planning now for the transition to all new pharmacists becoming prescribers at qualification for 2026, and could use PGDs before then to help current pharmacists to prescribe.

Related Article: ‘Streamlined’ DMS claims process to launch in July

He explained: ‘In the interim, you can plug that gap with PGDs, so you don’t have to wait for a prescribing pharmacist to come along before you can prescribe antibiotics for UTIs.’

When asked whether the right leaders were in place across ICSs, he said the situation was ‘extremely patchy’, and repeated his call - also made in an interview with The Pharmacist last month - for LPCs to ‘get involved very early on’ in ICS discussions.

However, Mr Lane praised the introduction of ICSs for pulling ‘silos’ from across health and social care together ‘for the benefit of the patient’.

Related Article: RPS new director for England will build a ‘vibrant future’ for pharmacy

He continued: ‘In other words, we leverage the best value of the pharmacy pound for the taxpayer in the system. And if we all focus on that, the money in the system will follow the patient, and the process will end up being the right process for the patient, particularly because we’ll have all the patient groups involved as well in that discussion.'

This comes after Mr Lane, acting in his capacity as NPA chair, released a statement yesterday calling for ‘urgent intervention’ from the Government and the NHS in England, with pharmacies already having to reduce services because chronic underfunding has made current service levels unsustainable.

Want news like this straight to your inbox?
Sign up for our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.